EPIRUS Biopharma
manufactures and commercialize biosimilar monoclonal antibodies. .. Read moreEPIRUS Biopharma
manufactures and commercialize biosimilar monoclonal antibodies. .. Read more
CEO
Add
News
Jun 19, 2020
Zolmax News
EPIRUS Biopharma: Financial Review: Epirus Biopharmaceuticals (OTCMKTS:EPRSQ) versus Synlogic (OTCMKTS:SYBX)
Jul 31, 2016
4-traders
EPIRUS Biopharma: EPIRUS BIOPHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Jul 27, 2016
BioPharma-Reporter
EPIRUS Biopharma: Epirus files for bankruptcy protection and hands Remicade biosim to Reliance Life Sciences
Jul 25, 2016
Reuters
EPIRUS Biopharma: BRIEF-Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
Jul 24, 2016
The Economic Times
EPIRUS Biopharma: Reliance Life gains global rights for copies of Infliximab
Jul 14, 2016
Business Wire
Press Release: EPIRUS Biopharma : Systemic Idiopathic Juvenile Arthritis Therapeutics Pipeline Report 2016 - Research and Markets
Jul 01, 2016
NewsMaker
Press Release: EPIRUS Biopharma :
Polyarticular Juvenile Idiopathic Arthritis (PJIA) Therapeutics & Drugs Pipeline Review 2016
Jun 24, 2016
Equities
EPIRUS Biopharma: Epirus Biopharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Jun. 14, 2016)
Jun 15, 2016
Sonoran Weekly Review
EPIRUS Biopharma: EPIRUS Biopharmaceuticals To Sell EPIRUS Netherlands to Polpharma (NASDAQ:EPRS)
Jun 14, 2016
BioPharma-Reporter
EPIRUS Biopharma: Cash-strapped Epirus to sell CHO platform and biosimilar IP to Polpharma for $3.5m
EPIRUS Biopharma Competitors
1
2
3
4
5
6
7
8
9
10